FDA Approves Ensacove for ALK-Positive Locally Advanced or Metastatic NSCLC

The FDA approved ensartinib (Ensacove, Xcovery Holdings) for adult patients with anaplastic lymphoma kinase ...

DECEMBER 19, 2024